Home » Newsletters » BioWorld Science

BioWorld Science

May 24, 2022

View Archived Issues

Loss of PHGDH potentiates metastatic dissemination

Kymera Therapeutics presents data on the IRAK4 degrader KT-474 in different cell subsets

Shenzhen Chipscreen Biosciences divulges PD-1/PD-L1 and/or CD80/PD-L1 interaction inhibitors

Idorsia Pharmaceuticals patents new LGALS3 inhibitors

Follicum AB and University of Bradford disclose compounds for skin and hair disorders

Boehringer Ingelheim Pharma KG identifies new EGFR mutant inhibitors

New c-Myc inhibitors presented by Suzhou Kintor Pharmaceuticals

Entrada's EEV treatments progress for Duchenne muscular dystrophy, myotonic dystrophy type 1

AKAP11 is a risk gene shared by bipolar disorder and schizophrenia

Salubris submits CTA in Europe for CTLA-4/IL-15 antibody fusion protein JK-08

FDA grants orphan drug designation to DepYmed's DPM-1001 for Wilson disease

KaliVir and Roche to collaborate on novel oncolytic vaccinia viruses

Aptamer and PinotBio extend collaboration to develop Optimer-drug conjugates

PharmaCyte studies pancreatic cancer therapy to treat malignant ascites

Anti-IL13RA1 eblasakimab reduces neuronal response to proinflammatory cytokines

Research on IL-38 mRNA expression in cancers supports Immunome's development of IMM-ONC-01

Elicio shows AMP vaccination significantly enhances TCR-T antitumor response in tumor model

Quoin enters research agreement with QUT to target VCAM-1:VL-4 interaction to treat scleroderma

Antigen-specific immunotolerance platform shows preclinical proof of concept for Parkinson's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...